Using Available Information in the Assessment of Diagnostic Protocols by Steiner, Stefan H. et al.
Volume 6 • Issue 1 • 1000217
J Biom Biostat
ISSN: 2155-6180 JBMBS, an open access journal
Research Article Open Access
Cotton et al., J Biom Biostat 2015, 6:1
http://dx.doi.org/10.4172/2155-6180.1000217
search Article Open Access
Biometrics & Biostatistics
Keywords: Binary diagnostic test; Sensitivity; Specificity; Likelihood 
ratios; Combined tests; Baseline data
Introduction
In screening and diagnostic testing, it is common for researchers to 
consider how a new diagnostic test might be combined sequentially with 
an existing test to either improve the overall diagnostic performance 
or to reduce the overall cost while maintaining performance. If we 
assume that the tests produce binary results there are two protocol 
choices. A believe the positive protocol produces a positive result for all 
combinations of the existing and new test results except when both tests 
are negative while a believe the negative protocol produces a positive 
result only when both tests are positive. In practice the tests may be 
applied in sequence so we refer to an add-on plan as one in which the 
existing test is used first with the new test applied to only a subset of 
subjects depending on the protocol in use. In a triage plan, the new 
test is used on all subjects and the results determine who receives the 
existing test. Therefore, with two binary tests, a total of four sequential 
diagnostic protocols are possible.
Sequential protocols are used in a wide variety of settings including 
computed tomography as an add-on test to pelvic ultra sonography in a 
believe the positive protocol for the diagnosis of suspected appendicitis 
in children in Peña et al. [1], and high-risk human papillama 
virus testing as a triage test to cytological screening in a believe the 
negative protocol for precancerous cervical lesions in Kotaniemi-
Talonen et al. [2]. Although we refer to existing and new tests either 
could itself be a protocol combining multiple tests as long as the final 
result is dichotomous. For example, Gyselaers et al. [3] designed a 
screening protocol for trisomy 21 detection in the first trimester using 
a combination of age and serum test results as a triage to identify 
intermediate risk cases for advanced ultrasound scanning.
Our purpose is to demonstrate the value, expressed in terms 
of improved precision of important estimators, of using available 
information on the performance of the existing test, in combination 
with data from an assessment study of the existing and new tests to 
assess the properties of a combined protocol and compare the protocol 
to the existing test.
The available information or baseline data takes the form of 
a previous case-control study used to estimate the sensitivity and 
specificity of the existing test [4,5]. Initially, we confine ourselves to the 
setting where the assessment study is also a case-control study using 
a paired design (i.e. both tests are applied to all subjects). We assume 
that verification via a gold standard is available for both the assessment 
study and the baseline data. Later we discuss the use of cohort studies, 
where the numbers of diseased and non-diseased subjects are not fixed, 
and non-paired sequential assessment studies, where the new test is 
given to only a subset of subjects.
We make a key assumption that the diagnostic properties 
(sensitivity and specificity) of the existing test are the same in the 
baseline and assessment studies. Practically, this means selecting a 
source of baseline data with a population and test implementation as 
similar as possible to the assessment study. Depending on the disease 
under study, important population factors might include age- and 
sex-distributions and disease strain or severity in the cases. We derive 
a formal test of this hypothesis. If we reject the hypothesis then it is 
likely not appropriate to incorporate the baseline data into the analysis 
and either a new source of baseline data should be found or a standard 
analysis of the assessment study should be conducted. However, if we 
fail to reject the hypothesis, we will proceed with incorporating the 
available baseline data into the analysis of the combined protocol.
To assess the properties of the new protocol, we use maximum 
likelihood estimation for the sensitivity and specificity and asymptotic 
properties of the likelihood to find approximate standard errors. The 
comparison of the new protocol versus the existing test is made via 
likelihood ratios. These capture the trade-off between sensitivity and 
specificity of the new protocol versus the existing test [6-8]. Informally, 
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Abstract
A new binary screening or diagnostic test may be combined sequentially with an existing test using either a believe 
the positive or believe the negative protocol. Interest then lies in estimating the properties of the new combined protocol 
and in comparing the new protocol with the existing test via sensitivity, specificity, or likelihood ratios that capture the 
trade-off between sensitivity and specificity. We consider a paired assessment study with complete verification via 
a gold standard. Our goal is to quantify the gain in precision for the estimators of the sensitivity, specificity and the 
ratio of likelihood ratios in protocols when baseline information on the performance of the existing test is available. 
We find maximum likelihood estimators of the quantities of interest and derive their asymptotic standard deviations. 
The methods are illustrated using previously published mammography and ultrasound test results from a cohort of 
symptomatic women. We find that incorporating baseline information has a large impact on the precision of the estimator 
for the specificity of the believe the positive protocol and of the sensitivity of the believe the negative protocol. Including 
available baseline information can improve the precision of estimators of the sensitivity, specificity, and the ratio of 
likelihood ratios and/or reduce the number of subjects needed in an assessment study to evaluate the protocol.
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the positive (negative) likelihood ratio represents how many times 
more often a subject with the disease is expected to have a positive 
(negative) test result than one without the disease. The comparison 
between likelihood ratios is equivalent to comparing the predictive 
values of the two tests, when applied to the same population of subjects.
Likelihood ratios have previously been used by Nofuentes and del 
Castillo [9] to compare and test for differences between two binary 
tests and by Macaskill et al. [7] to compare a combined test with one 
of its components. Muwonge et al. [10] considered the sensitivities, 
specificities, and likelihood ratios for combinations of screening tests 
for cervical cancer. Bossuyt et al. [11] discussed the various ways of 
combining a new with an existing diagnostic test and Hayen et al. [8] 
discussed estimation of the likelihood ratios for a full paired design. 
Ahmed et al.  [12] and Ahmed et al. [13] considered three logic rules for 
combining two tests based on continuous markers and compared them 
in terms of the false positive rate, the maximum receiver operating 
characteristic curve, and overall cost. While sequential tests are 
relatively common in medicine, we are not aware of previous work on 
incorporating baseline data. The use of baseline data is more common 
in industrial applications [14,15].
The remainder of the article is organized as follows. In the Methods 
section we define notation and formulate the sensitivity and specificity 
of the combined protocols and the likelihood ratios used to compare 
the believe the positive or believe the negative protocol versus the 
existing test. We also derive the relevant asymptotic variances and 
discuss estimation. In the Application section we apply the methods to 
an example of the use of mammography and sonography/ultrasound 
for breast cancer detection in symptomatic women. Next we conduct a 
factorial experiment to study the gains in precision across a wide range 
of sensitivities, specificities and study sizes. Finally, we conclude with 
a discussion.
Methods
The results of a paired case-control assessment study of two binary 
diagnostic tests with verification via a gold standard can be summarized 
in two 2×2 tables, one for diseased subjects and one for non-diseased 
subjects. Let E and N be binary random variables representing the result 
(1 for a positive result, 0 for a negative result) of the existing and new 
tests, respectively. Let D be a binary random variable representing the 
disease status (1 for the diseased, 0 for the non-diseased). We denote 
the cell frequencies for the assessment study by en with e,n,d=0,1. Let 
n1 be the total number of diseased subjects in the assessment study
1 1 1 1
1 00 01 10 11( )n n n n n= + + + , n0 be the total non-diseased subjects, and 
1 0n n n= + be the total sample size. 
We define Pr[ , | ]den E e N n D dp = = = = to be the joint probability of 
the results of the existing and new tests conditional on disease status. 
Using the convention of a + indicating marginalization or summation 
over that subscript, the sensitivity and specificity of the existing test 
from the paired assessment study are given by:
1 1
1 0( 1| 1) 1π π+ += = = = = −Esens Pr E D                 (1)
0 0
1 0( 0 | 0) 1 π π+ += = = = − =Espec Pr E D                 (2)
Additionally, we assume we have available baseline information 
about the performance of the existing test. We denote these data by
d
em , e, d=0,1. The total number of diseased subjects in the baseline is 
denoted by m1, the number of non-diseased subjects by m0, and the total 
sample size for the baseline study by m=m1 + m0. An example of data 
of this type is given in Table 1 which will be discussed in detail in the 
Application section. Before we incorporate the available information 
in the estimation of the properties of a believe the positive or believe 
the negative protocol we recommend testing the equivalence of the 
sensitivity and specificity estimates of the existing test in the baseline 
and assessment studies. A likelihood ratio test for this purpose is given 
in Appendix A of the Supplementary Materials. Assuming we do not 
reject the equivalence hypothesis, we now develop the methodology 
necessary to incorporate the available information into the estimation 
of the properties of a believe the positive or believe the negative 
protocol.
Believe the positive protocol
When two tests are combined there is always a trade-off between 
the sensitivity and specificity of the new protocol and the existing test. 
Believe the positive protocols are used to reduce the number of false 
negatives and therefore increase the sensitivity over the existing test. 
Since a positive result on either the existing or new test yields a positive 
protocol result we will denote the protocol as E NÈ . The conditional 
probabilities of the existing test and the believe the positive protocol 
results, given the true disease status, can be expressed in terms of the 
conditional probabilities corresponding to the cell frequencies in a 
paired assessment study. For D=1, these conditional probabilities are:
( ) ( )
( ) ( )







Pr 1, 1| 1 Pr 1| 1
Pr 0, 1| 1 Pr 0, 1| D 1




+= = = = = = = + =
= = = = = = = =




E E N D E D
E E N D E N
E E N D E N
        (3)
and similarly for D=0. Note that we can write 1 1 100 1 011π π π+= − − and
0 0 0
00 1 011π π π+= − − .
The sensitivity and specicity of the believe the positive protocol can 
be expressed as:
1 1
1 011| 1)  (  π π+= = == + E Nsens Pr E N D                                 (4)
0 0
1 010 | 0)  (  1 π π+= = = −= − E Nspec Pr E N D                                    (5)
Through comparisons to Equations (1) and (2), note that 
≥
E N Esse s ensn  and ≤E N Essp c pece . Therefore, since higher sensitivity 
and specificity are desirable, there is a trade-off as the believe the 
positive protocol will always have a sensitivity at least as large as the 
existing test, and a specificity no greater than the existing test.
We can also compare the existing test and the new protocol in 
terms of their positive predictive values (PV+) and negative predictive 
values (PV-)
( ) ( ) 1 | 1 ; 0 | 0
1| 1)( ; 0 | ( 0) + −
+ −= = = = = =




E N E N
PV Pr D E PV Pr D E
PrP D E N Pr D E NV PV
As the predictive values are post-test probabilities of disease 
(non-disease) among the population of subjects who tested positive 
(negative), they are important from a clinical point of view. The trade-
Paired assessment study data Baseline data
Breast cancer cases Non breast cancer controls Non-
CasesUS+ US- Total US+ US- Total Cases
Mx+ 148 34 182 Mx+ 8 21 29 Mx+ 98 1062
Mx- 48 10 58 Mx- 20 184 204 Mx- 40 9208
Total 196 44 240 28 205 233 138 10270
Table 1: Results of mammogram (Mx) and ultrasound (US) screening from the 
parallel assessment study of Houssami et al. [16] and mammogram baseline data 
from Kavanagh et al. [17].
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off between specificity and sensitivity does not necessarily translate 
into a trade-off between the two predictive values. It is possible for 
the believe the positive protocol to have higher positive and negative 
predictive values than the existing test. However, it is well known that 
the predictive values of a test depend on the accuracy of the test and 
the disease prevalence [7]. Therefore, a direct comparison between the 
predictive values of two tests is not recommended, as the results of the 
comparison cannot be extended beyond the population on which the 
assessment study was conducted.
Macaskill et al. [7] and Hayen et al. [8] propose comparing the 
new protocol with the existing test by looking at the logarithm of the 
ratio of their corresponding positive and negative likelihood ratios. 
The likelihood ratios of the two tests can be expressed in terms of the 
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Marshall [6] shows that comparing the predictive values of two 
tests is equivalent to comparing the likelihood ratios of these tests, for 
fixed prevalence. That is, for fixed prevalence,
 if and only if + + + +≥ ≥
 E EN E N EPV PV LR LR
and
 if and only if − − − −≥ ≤
 E EN E N EPV PV LR LR
However, since the likelihood ratios do not depend on the disease 
prevalence we can compare the estimates of the likelihood ratios 
from the assessment study directly. This comparison translates into a 
comparison between the predictive values of the tests when applied to 
the same population. 
The expressions for the logarithm of the ratios of the positive and 







, respectively, in terms of the conditional 
probabilities, are as follows:
1 1 1 0 0 0
1 01 1 1 01 1ln ln( ) ln( )] [ln( ) l[ n( )]π π π πφ π π
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+ + + ++= + − − +
 
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LR        (7)
If the believe the positive protocol is better than the existing test 
in terms of both the positive and negative predictive values then 




. However, it might be that the new protocol is 
better than the existing one in terms of the positive predictive value, 
but worse in terms of the negative predictive value, or the other way 
around.
Analysis for the believe the positive protocol
In this section, our goal is to quantify the gain in precision for 
the estimators of sensitivity and specificity of the believe the positive 






that comes from incorporating the available baseline 
information into the estimation procedure.
Assuming independence between the baseline and assessment 
data, we can write the likelihood function as b sL L Lµ ´ where Lb is the 
baseline likelihood
01 1 0
0 11 1 1 10 0
1 1
1 1
1 1( ) (1 ) ( 1)  ( )ππ ππ
−−
+ + + +−∝ − ×
mm
b
mm m mL                  (8)




011 n n nn1 1 0 0 0 0
1 01 1 01 1
1 1
1 1 00 1(1  ) ( ) ( ) (( ) ( ) 1 )ππ π π π π ππ+ ++ + + +− − × − −∝
nn
sL        (9)
Note that here we assume that the sensitivity ( 11π + ) and specificity 
( 011 π +− ) of the existing test are the same in the baseline and assessment 
studies. This assumption should be tested as outlined in Appendix A of 
the Supplementary Materials. Using the combined likelihood function, 
the maximum likelihood estimates (MLEs) of the four conditional 
probabilities are










D D DD D
D D D D
D
D D D D D
m n m n nm n
m n m n n n
, for D =0,1.                  (10)
The MLEs of the sensitivity and specificity of the believe the positive 
protocol and of the log-ratios of the likelihood ratios are obtained by 
substituting the MLEs given in Equation (10) into Equations (4-7).
The asymptotic variances of the estimators of 
, , andE N E N E N E Nsens spec f f
+ -
   
 are found using the delta method 
(see the Appendix B of the Supplementary Materials for complete 
derivations). Given the numbers of diseased and non-diseased subjects 
in the assessment study and the baseline data, the asymptotic variances 
for the estimators of E Nsens   and E Nspec   are 
  
1 1 1 1 1 1 1 1 1
1 1 1 01 01 1 1 01 1 1 1 01
1
1 1 1 1 1 1




π π π π π π π π π
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n m n n m                  (11)

0 0 0 0 0 0 0 0 0
1 1 1 01 01 0 1 01 0 0 1 01
0
0 0 0 0 0 1
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+ + −E N
n n mspec
n m n n m
     (12)
For the estimators of E Nf
+

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+ + − −
+ + −
E N
m n m n
n n m
m n m n
n n m
       (13)
1 0
01 01
1 1 1 0 0 0
1 1 01 1 0 1 01 1
v ˆr[ ]
(1 )(1 ) (1 )(1 )
a π πφ
π π π π π π
−
+ + + +
= +
− − − − − −E N n n                (14)
If no baseline data are available, the MLEs and expressions for the 
asymptotic variances can be obtained by substituting 1 0 0m m= =  
in Equation (10) and Equations (11-14), respectively. We note here 
that even when it is available, the MLE for E Nf
-

 and the expression 
for its asymptotic variance given by Equation (14) do not depend on 
the baseline data. However, the asymptotic variances of,  E Nsens   

 E Nspec  and E Nf
+

  are always reduced by including the baseline data.
Equations (11-14) are used to derive the standard errors for 
the estimates of sensitivity and specificity of the believe the positive 
protocol, and for the log-ratios of the positive and negative likelihood 
ratios of the two tests, by replacing the values of 1π +D , and 01π
D , D=0,1, 
with their corresponding MLEs, and then taking the square root. In cases 
where the sample size for the assessment study is small or the counts 
for some denn  are very small, other methods such as bootstrapping are 
recomended for obtaining the standard errors [7].
Believe the negative protocol
Believe the negative protocols are used to reduce the number of false 
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subjects in the assessment study and the baseline data, the expressions 
for the asymptotic variance for the estimations of E Nsens Ç , E Nspec Ç ,
E Nf Ç
+ , and E Nf Ç
- are

1 1 1 1 1 1 1 1 1
0 0 0 10 10 1 0 10 1 1 0 10
1
1 1 1 1 1 0
(1 ) 2 [ ( )(1 )]var[ ]
( )(1 )
π π π π π π π π π
π
+ + + + +
+





n m n n m
  (21)

0 0 0 0 0 0 0 0 0
0 0 0 10 10 0 0 10 0 0 0 10
0
0 0 0 0 0 0
(1 ) 2 [ ( )(1 )]var[ ]
( )(1 )
π π π π π π π π π
π
+ + + + +
+
− − + + − −
= +
+ + −E N
n n mspec




1 1 1 0 0 0
1 0 10 0 0 0 10 0
ˆvar[ ]
(1 )(1 ) (1 )(1 )
π πφ
π π π π π π
+
+ + + +
= +
− − − − − −E N n n             (23)
1 1 1 1 1 1
10 1 0 0 10 1 1 0 1 0
1 1 1 2 1
1 1 1 0 0 10 0
[ ( )( )]ˆvar[ ]
( ) ( ) (1 )
π π π π π πφ
π π π π
− + + + +
+ + +
+ + − −
= +
+ + −E N
m n m n
n n m
                 
0 0 0 0 0 0
10 0 0 0 10 0 0 0 0 0
0 0 0 2 0
0 0 0 0 0 10 0
[ ( )( )]
( ) ( ) (1 )
π π π π π π
π π π π
+ + + +
+ + +
+ + − −
+ + −
m n m n
n n m
             (24)
There is a clear symmetry between these results and those for the 
believe the positive protocol in Equations (11-14). If baseline data are 
not available, the MLEs can be obtained by substituting 1 0 0m m= =  
into the relevant equations. For the believe the negative protocol the 
MLE for E Nf Ç
+  and the expression for its asymptotic variance given by 
Equation (23) do not depend on the baseline data.
Additional Considerations 
Add-on and triage plans: The believe the positive and believe the 
negative protocols determine the rule for combining the results of the 
two tests. In practice the protocols can be implemented using either 
an add-on or triage plan. In an add-on plan the existing test is first 
given to all subjects. Follow-up testing with the new test is conducted 
only on those with an initial negative results for believe the positive 
or initial positive result for believe the negative. For a triage plan, the 
new test is used first and the results determine who will receive the 
existing test. The choice of plan and protocol comes down to scientific 
and practical considerations. For instance if the new test is invasive or 
expensive it may best be used as an add-on in a believe the negative 
protocol to improve sensitivity over the use of the existing test alone. 
This combination means that only subjects likely to be truly diseased 
(on the basis of a positive result from the existing test) are given the 
new test. The diagnostic properties of the protocols do not depend on 
whether they will be used with an add-on or triage plan.
Case-control versus cohort studies: The expressions for the MLEs 
in Equations (10) and (20) and the asymptotic variances in Equations 
(11-14) and Equations (21-24) apply to settings where the numbers of 
diseased, n1 and m1 and non-diseased, n0  and m0, in the assessment and 
baseline studies are fixed, as in a case-control design. If the assessment 
study is designed as a cohort study, these expressions still apply, with n1 
replaced by nq and n0  by ( )1n q- , where θ is the prevalence of disease 
and n is the total sample size. Similar adjustments can be made to m1 
and m0 if the baseline data come from a cohort study.
Paired versus sequential assessment studies: The analysis 
methodology given above assumes that a paired assessment study is 
used. If it is known a priori whether the new and existing tests will be 
combined using a believe the positive or believe the negative protocol 
a sequential assessment study can be used instead. We still assume full 
verification via a gold standard. First, the existing test should be applied 
to all subjects. This is necessary so that we can test for equivalence of 
the diagnostic properties of the existing test across the baseline data and 
assessment study. Following that, the new test should be applied to only 
positives and therefore increases the specificity over the existing test. 
We will denote the protocol as E NÇ . The conditional probabilities, 
given the true disease status, of the existing test and the believe the 







( 0, 0 | 1) (E 0 | D 1)
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and similarly for D=0. Note that we can write 1 1 111 1 101π π π+= − −  and 
0 0 0
11 1 101π π π+= − − . 
The sensitivity and specificity of the believe the negative protocol 
can be expressed as:
1 1 1
11 0 10( 1| 1) 1π π π+= = = = = − − NEsens Pr E N D                      (16)
0 0
0 10( 0 | 0) π π+= = = = + E Ns Pr E N Dpec                                    (17)
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Note that andE N E E N Esens sens spec specÇ Ç£ ³ . Therefore, as in 
the case of a believe the positive protocol, there is a trade-off between 
sensitivity and specificity, but this time the new protocol improves 
the specificity, but decreases the sensitivity. We can compare the 
performance of the existing test to the new protocol in terms of the 
logarithm of the ratio of their positive and negative likelihood ratios
1 1 1 0 0 0














LR   (18)
1 1 1 0 0 0
0 10 0 0 10 0ln [ln( ) ln( )] [ln(1 ) ln( )]π π π π π πφ
−
−
+ + + +−
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         (19)
For fixed prevalence, the comparison between the likelihood ratios 
translates into a comparison between predictive values, as explained for 
the believe the positive protocol. In practice, there may be situations 
where the believe the negative protocol is better than the existing test 
in terms of the positive predictive values and worse in terms of the 
negative predictive value, or vice versa.
Analysis for the believe the negative protocol
The analysis of the  believe the negative protocol mirrors the 
analysis of the believe the positive protocol. We reparameterize the 
likelihoods for the baseline and assessment study in terms of the four 
parameters 0π +
D , 10π
D , D=0,1 to obtain
01 1 0
0 11 1 1 11 1 0 0
0 0 0 01 ) ( ) (1 ) ( )( π π π π
−−
+ + + +− ×∝ −
m mm m m m
bL
1 1 0 01 0
0 10 0 1011 111 1 1 1 0 0 0 0
0 10 0 10 0 10 0 10) ( ) (1 ) ( ) ( ) ( )( 1π π π π π π π π+ ++ + + +− − × − −∝
n n n nn n
sL
The MLEs of the four conditional probabilities are  
0 0 0 0 10
0
0 10




ˆ  π π+ +
+
+
+ + − −
= = =
+ + −
D D D D D
D D
D
D D D D D
D Dm n m n m n D
m n m n n n
               (20)
The MLEs of the sensitivity and specificity of the believe the negative 
protocol and of the log-ratios of the likelihood ratios are obtained by 
substituting the MLEs given in Equation (20) into Equations (16-19).
Conditioning on the numbers of diseased and non diseased 
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those subjects with an initial negative result for a believe the positive 
protocol or initial positive result for a believe the negative protocol. 
This means we do not observed the full 2×2 data tables. However, the 
MLEs and asymptotic variance expressions under a believe the positive 
protocol in Equations (10-14) only depend on 1
Dn +, 01
Dn  and nD so it is 
not necessary to separately observe ( 11
Dn , 10
Dn ), D=1,0. The same holds 
for a believe the negative protocol where it is not necessary to separately 
observe ( 01 00,
D Dn n ), D=1,0.
Application
As an example, we consider breast cancer detection in symptomatic 
women. In a case-control study, Houssami et al. [16] examined the 
mammography (Mx) and sonography/ultrasound (US) test results 
of 240 women shown to have breast cancer and 233 age-matched 
controls. Both cases and controls were women aged 25 to 55 years 
who had been referred to testing due to the presence of symptoms (a 
palpable lump, pain or localized discomfort, etc.). The controls were 
selected among those who were not diagnosed with breast cancer in 
the two years following their assessment. The images were interpreted 
by two radiologists blinded to the subject's cancer status. Since both 
the cases and controls were tested using both modalities, the paired 
data are available in Table 1. A complete discussion of the study 
design and inclusion and exclusion criteria is available in Houssami 
et al. [16]. While the original purpose of the study was to investigate 
the age-specific sensitivity and specificity of the tests, we will use the 
data as an illustration to evaluate whether ultrasound is useful when 
combined with mammography in a believe the positive or believe the 




USsens =81.6%, and USspec =88.0%. To illustrate, we 
treat mammography as the existing test and ultrasound as a new test. 
Among the cases and controls, 34.1% and 17.6%, respectively, of the 
women had discrepant mammography and ultrasound test results.
In order to proceed with the methods described in the previous 
section, we need baseline data on the performance of mammography in 
the given population. We use the data provided in Kavanagh et al. [17] 
for this purpose (see Table 1-Baseline data) which provide estimates 
of the sensitivity and specificity of mammography in a similar 
symptomatic population. We consider the subpopulation of women 
with any breast symptoms and estimate the sensitivity and specificity 
of mammography to be 71.0% and 89.7%, respectively. Both studies 
were conducted among Australian women in the mid 1990's. However, 
the population in the baseline study was slightly older which may 
cause an inflation of the sensitivity estimate. However, the likelihood 
ratio test derived in Appendix A of the Supplementary Materials 
gave no evidence (p-value=0.35) to reject the hypothesis that the two 
accuracy measures are common for the assessment study and baseline 
population We consider two diagnostic protocols:
1. Mx ⋃ US, a believe the positive protocol with US as an add-on 
to Mx. This protocol will have better sensitivity than Mx alone and uses 
US to catch potential initial false negatives. 
2. US ⋂ Mx, a believe the negative protocol with US as a triage 
for Mx. The protocol will have better specificity than Mx alone and in 
practice would greatly reduce the number of mammograms used in a 
screening program. 
The MLEs for the sensitivity and specificity of these diagnostic 
protocols under both a standard analysis (without baseline data) and 
an augmented analysis (with the inclusion of baseline data) are shown 
in Table 2. Here, we are interested in assessing the gain in precision in 
estimating the sensitivity and specificity of the new protocols when we 
include the baseline data in the analysis. We note that, for the believe 
the positive protocol, the estimates of both sensitivity and specificity 
are similar with and without the inclusion of the baseline data (around 
96% sensitivity and 80% specificity). Also, the precision of the estimator 
of sensitivity does not change noticeably when we include the baseline 
data. However, the standard error for the estimate of the specificity 
decreases by 30%. For the believe the negative protocol, the estimates 
given by the two analyses are also similar. There is a decrease of 10% in 
the standard error of the sensitivity estimate and 25% for the specificity 
estimate when the baseline data are included in the analysis.
For both protocols, the estimates of the logarithm of the ratio of 
positive and negative likelihood ratios and their associated standard 
errors for the standard and augmented analysis are also given in Table 
2. For the believe the positive protocol, the MLE for the logarithm of 
the ratio of positive likelihood ratios, Mx USf
+
È , is negative for both the 
standard and augmented analyses, although it is more extreme for the 
augmented analysis (i.e., -0.290 versus -0.359). The standard error of 
the estimate of Mx USf
+
È  decreases by around 17% when the baseline 
data are used in estimation. The estimate of the log-ratio of the negative 
likelihood ratios for the believe the positive protocol, Mx US ,f È
-
 is 
identical for the standard and augmented analyses (i.e., -1.655). The 
corresponding standard errors are very similar, with a slight decrease 
when the baseline data are used (about 4%).
When ultrasound is included in a believe the negative protocol, the 
MLE of the log-ratio of the negative likelihood ratios , US Mx ,f
-
Ç given 
by the augmented analysis is smaller than the one given by the standard 
analysis (0.347 compared to 0.363). The standard error of the estimate 
decreases by 17% when the baseline data are used. The estimates of 
the log-ratio of the positive likelihood ratios, US Mx ,f Ç
+  are identical 
(i.e. 1.081) for the standard and augmented analyses. However, the 
corresponding asymptotic standard error is slightly larger for the 
augmented analysis than for the standard analysis. To investigate this 
counterintuitive result, we conducted a simulation study in which the 
true parameter values and sample sizes are assumed to equal the relevant 
proportions from the three 2×2 tables in Table 1. The results, given in 
Table 3, indicate that the asymptotic standard error from the standard 
analysis underestimates the standard deviation corresponding to 
US Mx ,f Ç
+






 ) and its asymptotic standard deviation do not depend on 
the baseline data. We note a similar situation for the standard error of 
the estimate of Mx USf È
-  from both the augmented and standard analysis 
Sensitivity Specicity f+ f-
Believe the positive protocol (Mx ⋃ US)
Standard Analysis 0.958 (0.013) 0.790 (0.027) -0.290 (0.123) -1.655 (0.289)
Augmented Analysis 0.955 (0.013) 0.808 (0.019) -0.359 (0.102) -1.655 (0.279)
Believe the negative protocol (US ⋂ Mx)
Standard Analysis 0.617 (0.031) 0.966 (0.012) 1.081 (0.303) 0.363 (0.083)
Augmented Analysis 0.602 (0.028) 0.971 (0.009) 1.081 (0.331) 0.347 (0.069)
Table 2: Estimated sensitivity, specificity, and log-ratio of likelihood ratios (f+  and 
f- ) and (standard errors) for mammography (Mx) versus believe the positive 
(Mx ⋃ US) and believe the negative (US ⋂ Mx) protocols.
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which underestimates the corresponding standard deviation (0.289 
versus 0.317 for the standard analysis). The simulation study also 
suggests that the other asymptotic standard errors reported in Table 2 
are good approximations to their corresponding standard deviations.
Simulation Study
In the previous section, for the breast cancer screening example, 
we found that including baseline information generally improved the 
precision of the estimators of sensitivity and specificity of the new 
protocols, and of the logarithm of the ratio of positive likelihood ratios 
(for believe the positive) and negative likelihood ratios (for believe 
the negative). In order to investigate the magnitude of the potential 
precision gains across a variety of baseline and assessment study sizes 
and diagnostic accuracies, we conducted a factorial simulation study.
We considered four study sizes for the baseline data m0, m1=100, 
250, 1000, 5000 and two sizes for the paired assessment study n0, n1=100, 
250. Diagnostic accuracies of 70%, 80%, 90% were considered for each 
of sensE,  specE, sensN, and specN. In addition, the level of agreement 
between the two tests, represented through 111 Pr[ 1, 1| 1]π = = = =E N D
and, 000 Pr[ 0, 0| 0]π = = = =E N D  were set at 10%, 50%, 90% of the way 
between their minimum and maximum values given by (25) and (26):
( ) ( ) ( )max  1,  0    1,    1 |   1  mi  ,n+ ≤ = = =− ≤E N E Nsens sens Pr E N D sens sens   (25)
( ) ( ) ( )max  1,  0    0,    0 |   0  mi  ,n+ ≤ = = =− ≤E N E Nspec spec Pr E N D spec spec   (26)
This leads to a total of 46,656 scenarios. In each scenario the ratio 
of the asymptotic standard deviation of the estimators of the sensitivity, 
specificity, f+ and f- for an augmented (with baseline data) versus 
standard (no baseline data) analysis were calculated. Results showing 
the ratios of asymptotic standard deviations for a believe the positive 
protocol are presented in Figure 1 for varying baseline sample sizes 
m1 and m0. Results are similar for a believe the negative protocol with 
increased precision seen for f- rather than f+ . Over the scenarios 
considered, the median reductions in asymptotic standard deviation 
for the sensitivity, specificity, and f+ were 11%, 19%, and 19%, 
respectively.
The greatest precision improvements are found with larger baseline 
study sizes with the number of diseased m1 impacting the precision 
of E Nsens È , the number of non-diseased impacting the precision of
E Nspec È , and both jointly impacting the precision of E Nf È
+ . The gains 
in precision in the estimation of E Nsens È  also tend to be higher when 
the number of diseased subjects in the assessment study n1 is small, 
sensE is high, sensN is low, and the level of agreement between sensE and 
sensN is high. For E Nspec È the greatest gains in precision are found 
when n0 is small, specE is low, specN is high, and their agreement is 






greatest when specE is high, specN is low, and their agreement is low.
Discussion
In this paper, we provided methods for incorporating available 
baseline information into the estimation of the sensitivity and 
specificity of a new believe the positive or believe the negative protocol, 
and of the logarithm of the ratios of positive and negative likelihood 
ratios of the new protocol vs. the existing test. Comparison between the 
likelihood ratios of the new protocol and the existing test is equivalent 
to a comparison between the corresponding predictive values when 
applied to the same population. Asymptotic variances were derived for 
all proposed statistics.
Throughout the paper, we assumed that baseline data for the 
augmented analysis were available in the form of a 2×2 table. 
Alternatively, baseline data might only be available in the form of 
estimated sensitivity and specificity and their standard errors or 
confidence intervals. Provided the number of subjects is given, it is 
straightforward to transform a test's sensitivity and standard error 
to the data dem , e=0,1  and d=0,1 using formulas for the MLE and 
variance of a proportion from a binomial distribution. Additionally, 
the methods presented here could be expanded to include a second set 
of baseline data perhaps from a preliminary evaluation of the new test.
Before conducting an augmented analysis we propose using a 
likelihood ratio test of the equivalence of the diagnostic properties of 
the existing test across the baseline and assessment study data. If this 
test is rejected it suggests that the existing test is behaving differently 
between subjects in the baseline and assessment studies. This could be 
due to inherent differences in the populations (for example age, disease 
strain, disease severity) or differences in the application of the test. In 
this case it is unwise to incorporate the baseline data in the analysis and 
a standard analysis should be used by substituting m1=m0=0 into the 
formulas given in the Methods section.
Incorporating baseline data increases the precision of the 
estimators of the sensitivity and specificity of the protocol and of the 
log-ratio of negative (positive) likelihood ratios of the believe the 
positive (negative) protocol versus the existing test. We do not have 









+  do not depend on the baseline data. However, in 
a believe the positive protocol, where we get higher sensitivity due to 
an increased number of positive results, we may be more interested in 





+ whose estimation and precision does benefit from the 
inclusion of baseline data.
In terms of planning an assessment study, there are two key ways 
in which incorporating available information is beneficial. First, for 
Sensitivity Specificity f+ f-
Est ESE ASE Est ESE ASE Est ESE ASE Est ESE ASE
Believe the positive protocol (Mx ⋃ US)
Standard Analysis 0.958 0.013 0.013 0.790 0.027 0.027 -0.298 0.127 0.123 -1.702 0.317 0.289
Augmented Analysis 0.955 0.014 0.013 0.808 0.019 0.019 -0.353 0.103 0.102 -1.701 0.317 0.279
Believe the negative protocol (US ⋂ Mx)
Standard Analysis 0.617 0.031 0.031 0.966 0.012 0.012 1.132 0.342 0.303 0.366 0.084 0.083
Augmented Analysis 0.602 0.028 0.028 0.971 0.009 0.010 1.132 0.344 0.331 0.348 0.069 0.069
Table 3: Estimated sensitivity, specificity and log-ratio of likelihood ratios (f+ and f- ), empirical standard errors (ESE) and asymptotic standard errors (ASE) for 
mammography (Mx) versus believe the positive (Mx ⋃ US) and believe the negative (US ⋂ Mx) protocols from 50,000 simulations based on parameter values derived from 
the breast cancer example.
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a fixed assessment study size, using baseline data will improve the 
precision of the estimators of important quantities for the combined 
protocol. Second, for a fixed desired precision, the use of baseline data 
may substantially decrease the required sample sizes for the assessment 
study. Initial estimates of the properties of the new and existing test 
along with the expressions for asymptotic variances given in the 
Methods section can be used for planning purposes.
If the assessment study is run using a paired design the properties 
of all four combinations of protocol (believe the positive or believe the 
negative) and plan (add-on or triage) can be estimated. If the protocol 
is fixed a priori a sequential assessment study can be run with the 
existing test first applied to all subjects. This study mimics the use of 
an add-on plan and gives all the necessary information to compare the 
existing test with the new protocol, for both augmented and standard 
analysis. The results apply to either plan. However, in a sequential 
study mimicking a triage plan only the subjects testing positive with 
the new test are further tested with the existing test. Therefore, the 
sensitivity and specificity of the existing test cannot be estimated from 
the assessment study and therefore cannot be compared to the baseline 
results. An augmented analysis could still be conducted using methods 
similar to those developed in the Methods section.
In the example with breast cancer detection, neither the existing 
test nor the believe the positive protocol outperformed the other in 
terms of both positive and negative predictive values. In such cases 
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Figure 1: Ratio of the asymptotic standard deviation for an augmented analysis versus standard analysis for estimators of (a) sensitivity of E⋃N, (b) 
specificity of E⋃N, and (c) E NUf
+ for a believe the positive protocol across varying baseline sample sizes m1 and m0, assessment study sizes, and 
sensitivities and specificities of the new and existing tests.
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Macaskill et al. [7] propose choosing between the existing test and the 
protocol based on the expected numbers of additional false positive 
and true positive results identified by the believe the positive protocol. 
As this protocol involves testing with the new test the subjects who 
tested negative for the existing test, the believe the positive protocol 
will generate some additional false positives and true positives when 
compared to the results of the existing test only. For a believe the 
negative protocol one would compare the expected numbers of 
additional false negative and true negative results identified by the 
protocol. We do not further investigate this trade-off here but it may 
warrant future attention.
Supplementary Materials
Appendix A gives the derivation of a likelihood ratio test for testing 
the equivalence in the diagnostic properties (sensitivity and specificity) 
of the existing test across the baseline data and assessment study. 
Appendix B gives the derivation of the asymptotic variances of the 
estimators of the sensitivity, specificity and log-ratios of the positive 
and negative likelihood ratios for a believe the positive protocol.
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